{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:40:09Z","timestamp":1791276009249,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jaut.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T04:41:01Z","timestamp":1278045661000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["B-cell delivered gene therapy for tolerance induction: Role of autoantigen-specific B cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Ai-Hong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun O.","family":"Onabajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Skupsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrn784","article-title":"New concepts in the immunopathogenesis of multiple sclerosis","volume":"3","author":"Hemmer","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jaut.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1084\/jem.20030320","article-title":"Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year","volume":"197","author":"Steinman","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4049\/jimmunol.127.4.1420","article-title":"Adoptive transfer of experimental allergic encephalomyelitis in SJL\/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes","volume":"127","author":"Pettinelli","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/317355a0","article-title":"T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination","volume":"317","author":"Zamvil","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2010.05.002_bib5","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"130","author":"Linington","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI3568","article-title":"Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis","volume":"102","author":"Qin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.54.6.1227","article-title":"Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response","volume":"54","author":"Smith-Jensen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/240564b0","article-title":"Protection against experimental allergic encephalomyelitis","volume":"240","author":"Teitelbaum","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0090-1229(87)90118-8","article-title":"Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone","volume":"45","author":"Lublin","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaut.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(95)00160-3","article-title":"Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis","volume":"64","author":"Yu","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrg2395","article-title":"The genetics of multiple sclerosis: SNPs to pathways to pathogenesis","volume":"9","author":"Oksenberg","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaut.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.158.5.2174","article-title":"Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients","volume":"158","author":"Zambidis","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.4049\/jimmunol.168.9.4788","article-title":"Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases","volume":"168","author":"Melo","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2003.12.013","article-title":"A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP","volume":"111","author":"Xu","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymthe.2005.09.002","article-title":"Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE","volume":"13","author":"Xu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaut.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.gt.3302327","article-title":"Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?","volume":"11","author":"Song","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.jaut.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1182\/blood-2004-11-4274","article-title":"Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins","volume":"105","author":"Lei","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clim.2005.08.007","article-title":"B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis","volume":"118","author":"Liang","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2006.06.004","article-title":"Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells","volume":"240","author":"Soukhareva","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI9168","article-title":"Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis","volume":"106","author":"Agarwal","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/art.22566","article-title":"Mycobacterial Hsp65-IgG-expressing tolerogenic B cells confer protection against adjuvant-induced arthritis in Lewis rats","volume":"56","author":"Satpute","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1182\/blood-2004-01-0091","article-title":"Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.4049\/jimmunol.0901777","article-title":"In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness","volume":"183","author":"Ahangarani","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.4049\/jimmunol.165.10.5631","article-title":"Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells","volume":"165","author":"El-Amine","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4049\/jimmunol.175.2.780","article-title":"Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction","volume":"175","author":"Litzinger","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4049\/jimmunol.181.2.1153","article-title":"B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway","volume":"181","author":"Su","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2010.95","article-title":"B-cell delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells","author":"Skupsky","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaut.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.188.1.169","article-title":"B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice","volume":"188","author":"Litzenburger","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2010.05.002_bib31","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.167.10.5535","article-title":"B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice","volume":"167","author":"Hulbert","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.4049\/jimmunol.153.10.4349","article-title":"Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB\/H mice","volume":"153","author":"Amor","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/nprot.2006.285","article-title":"Active induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jaut.2010.05.002_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat Rev Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jaut.2010.10.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000}}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:01:12Z","timestamp":1760256072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841110000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0896841110000545"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2010.05.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jaut.2010.10.001","asserted-by":"object"}]},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell delivered gene therapy for tolerance induction: Role of autoantigen-specific B cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2010.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}